3.35
Schlusskurs vom Vortag:
$3.23
Offen:
$3.23
24-Stunden-Volumen:
52,170
Relative Volume:
0.33
Marktkapitalisierung:
$2.48M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-8.82M
KGV:
-0.00485
EPS:
-691.4213
Netto-Cashflow:
$-8.08M
1W Leistung:
+7.72%
1M Leistung:
-44.17%
6M Leistung:
-41.33%
1J Leistung:
-99.32%
Endra Life Sciences Inc Stock (NDRA) Company Profile
Firmenname
Endra Life Sciences Inc
Sektor
Branche
Telefon
734-335-0468
Adresse
3600 GREEN COURT, ANN ARBOR, MI
Vergleichen Sie NDRA mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
NDRA
Endra Life Sciences Inc
|
3.35 | 2.30M | 0 | -8.82M | -8.08M | -691.42 |
![]()
TMO
Thermo Fisher Scientific Inc
|
402.82 | 148.60B | 42.90B | 6.52B | 6.72B | 17.05 |
![]()
DHR
Danaher Corp
|
189.90 | 132.07B | 23.82B | 3.77B | 4.90B | 5.15 |
![]()
IDXX
Idexx Laboratories Inc
|
513.36 | 40.34B | 3.93B | 894.97M | 837.70M | 10.82 |
![]()
A
Agilent Technologies Inc
|
111.92 | 30.82B | 6.63B | 1.17B | 1.19B | 4.05 |
![]()
IQV
Iqvia Holdings Inc
|
140.33 | 23.70B | 15.50B | 1.33B | 2.16B | 7.34 |
Endra Life Sciences Inc Aktie (NDRA) Neueste Nachrichten
Ascendiant Capital Maintains Buy Rating on ENDRA Life Sciences (NDRA) | NDRA Stock News - GuruFocus
Microchip Technology To Rally More Than 20%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga
ENDRA Life Sciences Faces Nasdaq Compliance Challenge - TipRanks
ENDRA Life Sciences: Strategic Shift and Financial Update - TipRanks
ENDRA Life Sciences Provides a Business Update and Reports First - GuruFocus
ENDRA Life Sciences (NDRA) Aims to Revolutionize Metabolic Disease Detection | NDRA Stock News - GuruFocus
ENDRA Life Sciences Q1 2025 Financial Results and Business Update - TradingView
ENDRA Life Sciences Inc. SEC 10-Q Report - TradingView
ENDRA Life Sciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Endra Life Sciences reports Q1 EPS ($1.86) vs ($449.58) last year - TipRanks
ENDRA Life Sciences Provides A Business Update And Reports First Quarter 2025 Financial Results - marketscreener.com
ENDRA Life Sciences Provides a Business Update and Reports First Quarter 2025 Financial Results - Stock Titan
ENDRA Life Sciences (NDRA) to Release Quarterly Earnings on Tuesday - Defense World
ENDRA Life Sciences Inc. (NASDAQ:NDRA) Short Interest Update - The AM Reporter
ENDRA Life Sciences Inc. (NASDAQ:NDRA) Sees Significant Growth in Short Interest - Defense World
ENDRA Life Sciences Inc (NDRA) Stock: A Year of Highs and Lows in the Market - investchronicle.com
What is ENDRA Life Sciences Inc (NDRA) Stock Return on Shareholders’ Capital? - Sete News
What Are You Thinking About Investing In ENDRA Life Sciences Inc (NASDAQ: NDRA) Stock? - Stocksregister
ENDRA Life Sciences Inc: Navigating Market Fluctuations with a 1.74M Market Cap - investchronicle.com
Why Vertiv Holdings Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket - Benzinga
ENDRA Life Sciences Deploys TAEUS Tech to Improve Metabolic Disease Detection - Medical Product Outsourcing
A Guide To The Risks Of Investing In ENDRA Life Sciences Inc (NDRA) - knoxdaily.com
ENDRA Life Sciences (NASDAQ:NDRA) Given New $50.00 Price Target at Ascendiant Capital Markets - Defense World
NDRA stock touches 52-week low at $3.05 amid sharp annual decline By Investing.com - Investing.com South Africa
NDRA stock touches 52-week low at $3.05 amid sharp annual decline - Investing.com India
Reshape Lifesciences Stock Price, Quotes and Forecasts | NASDAQ:RSLS - Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
ENDRA Life Sciences Stock Gains Market Momentum - Stocks Telegraph
ENDRA Life Sciences Advances TAEUS Liver Device Strategy - TipRanks
ENDRA Life Sciences pivots to metabolic health market - Investing.com
ENDRA Life Sciences Inc. (NDRA) reports earnings - Quartz
ENDRA Life Sciences Inc. SEC 10-K Report - TradingView
How ENDRA's AI-Powered Device Could Transform GLP-1 Weight Loss Treatment Monitoring - Stock Titan
ENDRA Slashes Monthly Expenses 37% as TAEUS Liver Device Advances - Stock Titan
ENDRA Life Sciences Inc expected to post a loss of $4.10 a shareEarnings Preview - TradingView
ENDRA Life Sciences (NDRA) Projected to Post Earnings on Thursday - Defense World
ENDRA Life Sciences Strengthens TAEUS® System Intellectual Property with Issuance of 24th U.S. Patent - Business Wire
ENDRA Life Sciences stock hits 52-week low at $3.89 amid steep decline - Investing.com Canada
ENDRA Life Sciences Announces New Clinical Study Partnership with Inselspital University Hospital in Bern, Switzerland - ACCESS Newswire
Critical Contrast: ENDRA Life Sciences (NASDAQ:NDRA) vs. Gadsden Properties (OTCMKTS:GADS) - Defense World
ENDRA Life Sciences to Participate at Upcoming Investor Conferences - ACCESS Newswire
ENDRA Life Sciences Strengthens Global Intellectual Property Protection with Issuance of Two European Patents Related to its TAEUS Probe - ACCESS Newswire
ENDRA Life Sciences Issued Chinese Patent for Its TAEUS(R) Platform Technology to Calculate Fat Concentration in Tissue - ACCESS Newswire
Where are the Opportunities in (NDRA) - Stock Traders Daily
What Makes ENDRA Life Sciences (NDRA) a New Strong Buy Stock - MSN
Financial Contrast: NeurAxis (NASDAQ:NRXS) versus ENDRA Life Sciences (NASDAQ:NDRA) - Defense World
(NDRA) On The My Stocks Page - Stock Traders Daily
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.36% - MSN
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.14% - MSN
(NDRA) Trading Signals - Stock Traders Daily
Finanzdaten der Endra Life Sciences Inc-Aktie (NDRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):